{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-21-A\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=A\n|Title=Thymoregulators: knowing the main classes and molecules\n|Description=None\n|Rubric=Definition\n|Contributors=\n|Order=21}}\nThymoregulators'' are ''psychotropic'' drugs whose main clinical action is to '''reduce the frequency''', '''duration''' and '''intensity''' of '''thymic episodes''' (manic and depressive).\n\nThey represent a fairly restricted pharmacological class which includes :\n\n* lithium salts,\n* anticonvulsant thymoregulators: valpromide, sodium divalproate, carbamazepine, lamotrigine, etc.",
  "question": {
    "properties": {
      "question": "Which of the following is NOT a characteristic of thymoregulators?",
      "option_a": "Reduce the frequency of thymic episodes",
      "option_b": "Reduce the duration of thymic episodes",
      "option_c": "Increase the intensity of thymic episodes",
      "option_d": "Reduce the intensity of thymic episodes",
      "correct_option": "C"
    },
    "required": [
      "question",
      "option_a",
      "option_b",
      "option_c",
      "option_d",
      "correct_option"
    ]
  }
}